Cancer cells exhibit altered metabolism where they rely heavily on glycolysis for energy production, even under oxygen-rich conditions. This metabolic shift allows cancer cells to rapidly proliferate. The high glucose consumption by cancer cells is often visualized using Positron Emission Tomography (PET) scans, where radiolabeled glucose analogs highlight areas of high metabolic activity.
